Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Quantum Biopharma (QNTM) Operating Expenses (2019 - 2025)

Quantum Biopharma's Operating Expenses history spans 7 years, with the latest figure at $2.4 million for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 5.14% to $2.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $15.3 million, a 25.92% increase, with the full-year FY2025 number at $15.3 million, down 5.17% from a year prior.
  • Operating Expenses hit $2.4 million in Q4 2025 for Quantum Biopharma, down from $4.7 million in the prior quarter.
  • Over the last five years, Operating Expenses for QNTM hit a ceiling of $12.7 million in Q2 2021 and a floor of $1.9 million in Q2 2023.
  • Historically, Operating Expenses has averaged $4.7 million across 5 years, with a median of $3.5 million in 2024.
  • Biggest five-year swings in Operating Expenses: surged 264.35% in 2021 and later tumbled 77.07% in 2024.
  • Tracing QNTM's Operating Expenses over 5 years: stood at $12.7 million in 2021, then plummeted by 55.48% to $5.6 million in 2022, then tumbled by 41.38% to $3.3 million in 2023, then crashed by 31.84% to $2.3 million in 2024, then rose by 5.14% to $2.4 million in 2025.
  • Business Quant data shows Operating Expenses for QNTM at $2.4 million in Q4 2025, $4.7 million in Q3 2025, and $4.9 million in Q2 2025.